Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Pharmaceuticals

Oasmia spin-off to begin US vet oncology commercialization in H2

Swedish firm Oasmia Pharmaceutical has completed the spin-off of its veterinary oncology business into a US subsidiary called AdvaVet.

United States Pharmaceuticals

Bactana secures significant portion of new equity round

US microbiome discovery firm Bactana Animal Health has received $400,000 in financing from Connecticut Innovations.

Investments Pharmaceuticals

Anizome to bridge valley of death between microbiome research and commercialization

The first company focused on a commercial therapeutic microbiome discovery platform dedicated to animal health and nutrition has been created.

Pharmaceuticals Companion Animals

Avivagen to further push commercialization efforts with extra funding

Canadian company Avivagen has sourced Can$800,000 ($626,000) from the credit facility provided by Bloom Burton Healthcare Lending Trust.

Feed & Additives Pharmaceuticals

Orion secures European approval for Clevor canine emetic

Orion Animal Health has received European approval for Clevor 30mg/ml eye drops.

Europe Orion Animal Health

Pet innovation, vaccines help German industry fight stagnating antibiotic sales

A robust market for small animal innovations and vaccines has helped the German animal health industry report 3% growth in the latest financial year.

Germany Antiparasitics

Anatara outlines extra details of Detach deal with Zoetis

Australian firm Anatara Lifesciences has highlighted the key financial aspects of its recent agreement for Detach with Zoetis, 

Asia Pacific Australia

Supply issues see ImmuCell take a hit in Q1

US animal health firm ImmuCell has seen a decrease in sales during the first quarter of 2018 as it felt the impact of manufacturing problems.

Financial Results Pharmaceuticals

Anatara secures global livestock, equine deal for Detach with Zoetis

Anatara Lifesciences has signed an exclusive licensing agreement with Zoetis for the worldwide development, manufacture, distribution and marketing of Detach.

R&D Deals

Global fake veterinary medicines markets seen as high as $2bn

A new report indicates there is a growing world market for illegal animal medicines.

Pharmaceuticals Policy & Regulation

New EU rules on antimicrobials trigger dairy, meat trade ban fears

International meat and dairy traders are fighting to soften the impact of a clause in the EU's forthcoming new veterinary medicines regulation which, if unamended, could completely block imports into the EU from other countries.

EU Policy & Regulation

KindredBio shares climb with approval of Mirataz

Kindred Biosciences has seen its share price hit an all time high following approval of its Mirataz feline treatment in the US.

Kindred Biosciences Product Approvals
See All